Sequenom Sells Bioscience Business to Agena for $31.8M

Jun 02, 2014

|

NEW YORK (GenomeWeb) – Sequenom said after the close of the market Friday that it has sold its bioscience business, which includes its MassArray system, to Agena Bioscience for $31.8 million.

Sequenom had said in September that it would conduct a strategic review for the business, formerly called the Genetic Analysis segment, but at the time didn't offer details on the reason for seeking a potential sell off.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Even More Data to Mine

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

New Spaces in Connecticut

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Healthier, If Not Longer, Life

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

Main menu